Literature DB >> 9152047

Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity.

H Nishino1, M Kumazaki, A Fukuda, I Fujimoto, Y Shimano, H Hida, T Sakurai, S B Deshpande, H Shimizu, S Morikawa, T Inubushi.   

Abstract

Mechanisms underlying the selective vulnerability of the lateral striatal area to the toxic effects of 3-nitropropionic acid (3-NPA) were investigated in rats. A single exposure to 3-NPA (20 mg/kg, s.c.) induced no deficits in behavior and histology, but subsequent injection produced motor symptoms, catalepsy, lip smacking, abnormal gait, paddling, rolling, opisthotonos, tremor, recombence, somnolence and so on, in 30% of the animals within a few hours. Diffusion-weighted magnetic resonance imaging of the brains revealed an area of high signal intensity in the bilateral striata. By this stage (within a few hours), striatal astrocytes had become swollen and disintegrated. Extravasation of immunoglobulin G was detected, indicating blood-brain barrier (BBB) dysfunction. Electron microscopy revealed edema and disorganization of structures inside the astrocytic end-feet around the branches of the lateral striatal artery. Neurons were less vulnerable than astrocytes to the 3-NPA injury. Treatment of the rats with D2 receptor agonist prior to exposure to 3-NPA attenuated the behavioral abnormalities and histological damage whereas pretreatment with D2 antagonist exacerbated these changes. The concentrations of extracellular dopamine (DA) and dihydroxyphenyl acetic acid (DOPAC) were both increased in rats exposed to 3-NPA. In vitro imaging of astrocytes revealed a progressive increase in [Ca2+]i after superfusion with 3-NPA, and the 'ceiling' level was maintained even after extensive washing. DA superfusion also increased the astrocytic [Ca2+]i and this increase was reversible. Data indicate that 3-NPA-induced striatal damage was associated with astrocytic cell death and dysfunction of the BBB. Intracellular edema and extreme Ca2+ overload induced by the toxin were further aggravated by an increase in the level of DA activity. These factors acting either singly or in combination may trigger astrocyte destruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152047     DOI: 10.1016/s0168-0102(97)01170-x

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  13 in total

1.  Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia.

Authors:  Cynthia A Crawford; Garnik Akopian; Justin Ring; Michael W Jakowec; Giselle M Petzinger; Julie K Andersen; Philip Vittozzi-Wong; Kristie Wang; Cristal M Farley; Sergios Charntikov; Danut Mitroi; M Flint Beal; Robert Chow; John P Walsh
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

2.  Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Authors:  D Pubill; E Verdaguer; A M Canudas; F X Sureda; E Escubedo; J Camarasa; M Pallàs; A Camins
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Authors:  David Blum; David Gall; Marie-Christine Galas; Pablo d'Alcantara; Kadiombo Bantubungi; Serge N Schiffmann
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.

Authors:  Ernesto J Muñoz-Elías; John D McKinney
Journal:  Nat Med       Date:  2005-05-15       Impact factor: 53.440

Review 5.  Neurotoxicology of the brain barrier system: new implications.

Authors:  W Zheng
Journal:  J Toxicol Clin Toxicol       Date:  2001

6.  Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats.

Authors:  C E Teunissen; M Mulder; J de Vente; K von Bergmann; C De Bruijn; H W Steinbusch; D Lütjohann
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

7.  Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.

Authors:  Nicola Marchi; Giulia Betto; Vincent Fazio; Quinyuan Fan; Chaitali Ghosh; Andre Machado; Damir Janigro
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

Review 8.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

9.  Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.

Authors:  R M Moresco; T Lavazza; S Belloli; M Lecchi; A Pezzola; S Todde; M Matarrese; A Carpinelli; E Turolla; V Zimarino; P Popoli; A Malgaroli; F Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

10.  D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.

Authors:  Yan Wang; Xiaona Wang; Xinyu Zhang; Shuang Chen; Yanyun Sun; Wenlan Liu; Xinchun Jin; Guoqing Zheng
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.